Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait

Haemophilia

Volumn 5, Issue 4, 1999, Pages 273-275

  Kanyike, F B ^a   Abdul Salam, S A ^a   Prakash, B ^a   Sharhan, A ^a   Wahib, N ^a   Youssef, A H ^b  

^a AL AMIRI HOSPITAL   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

Bleeding; Circumcision; Haemophilia; Inhibitors; Recombinant factor VIIa; Treatment

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ARTICLE; BLEEDING; CASE REPORT; CIRCUMCISION; CLINICAL FEATURE; FEMALE; HEMOPHILIA A; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KUWAIT; PRIORITY JOURNAL; SCHOOL CHILD;

BLOOD LOSS, SURGICAL; CHILD; CIRCUMCISION, MALE; FACTOR VIIA; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; ISOANTIBODIES; KUWAIT; MALE; RECOMBINANT PROTEINS;

EID: 0032884252     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1999.00314.x     Document Type: Article

References (11)

1. White II GC. Coagulation factors V and VIII: Normal function and clinical disorders. In: Handin IR, Stossel TP, Lux SE, eds. Blood: Principles and Practice of Haematology Editors, 1st edn. Philadelphia: J.B. Lippincott, 1995: Ch. 39, 1151-79.
2. Prescott R, Nakai H, Saenko EL, Scharrer I, Nilsson IM, Humphries JE, et al. The inhibitor antibody response is more complex in haemophilia A patients than in most non-haemophiliacs with factor VIII antoantibodies. Recombinate Kogenate Study. Blood 1997; 89: 3663-71.
3. Krenz W, Escuriola-Ettingshavsen C, Martinez-Sanguer I, Gungor T, Kornhuber B. Epidemiology of inhibitors in haemophilia A. Vox Sanguinis 1996; 70 (Suppl. 1): 2-8.
4. Hay CR, Colvin BT, Ludlam CA, Hill FG, Preston FE. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemohpilia Centre Directors Organisation Inhibitor Working Party. Blood Coagulation Fibrinolysis 1996; 7 (2): 134-8.
5. White GC, Roberts HR. The treatment of factor VIII inhibitors - a general overview. Vox Sanguinis 1996; 70 (Suppl. 1): 19-23.
6. Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91 (1): 203-7.
7. Kavakii K, Aledort LM. Circumcision and haemophilia: a perspective. Haemophilia 1998; 4 (1): 1-3.
8. Martinowitz U, Varon D, Jonas P, et al. Circumcision in hemophilia: the use of fibrin glue for local hemostasis. J Urol 1992; 148, 855-7.
9. Ingerslev J, Freidman D, Gastineau D, et al. Major surgery in haemophiliac patients with inhibitors using recombinant factor VIIa. Haemostasis 1996; 26 (Suppl. 1): 118-23.
10. Schulman S, Lindstedt M, Alberts KA, Argren PH. Recombinant factor Vila in multiple surgery. Thromb Haemost 1994; 71: 154-61.
11. Ambriz FR, Quintana GS, Martinez MC, Dominguez GV, Rodriguez MH, Collazo JJ. Treatment of patients with haemophilia A and inhibitors to factor VIII with cimetidine. Arch Med Res 1996; 27 (1): 15-8.